UBS Group »

Decoy Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Decoy Therapeutics shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Decoy Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Decoy Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Decoy Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6k 546 6.53

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Decoy Therapeutics

UBS Group
Morgan Stanley

View all funds holding Decoy Therapeutics